ARCHIVES

Reports of SPOREs cut Premature, Broder Says, Wait for Peer Review

This article is from The Cancer Letter archive.

Vol. 18 No. 11 | March 13, 1992

Download PDF Visit The Full Archive

Related Articles

In Brief: FDA’s Burlington Moves to Wyeth-Ayerst; NAS Award to Beckman; Genetics Online

February 5, 1999

High Dose Chemotherapy Significantly Prolongs Survival In ECOG Clinical Trial

November 28, 2008

In Brief: Owens Gives Up Hopkins Hospital Presidency, Resume Full Time Role As Center Director

July 15, 1988

NCI Expects Improved Communications to Result from Consolidation of Offices

May 12, 2000

Chronobiology Review Still Delayed

May 5, 1989

ASCO, ONS Issue Standards For Safe Chemotherapy Administration

October 2, 2009